Back
Apellis Pharmaceuticals Stock Price Chart
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.
Sell
47
APLS
Apellis Pharmaceuticals
Last Price:
$19.29
Seasonality Move:
2.19%
7 Day Trial
ALL ACCESS PASS
$
7
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.-
The current trend is relatively stagnant and APLS is experiencing slight selling pressure.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.84 | Buy |
| 20-day SMA: | 17.92 | Buy |
| 50-day SMA: | 18.66 | Buy |
| 200-day SMA: | 27.56 | Sell |
| 8-day EMA: | 18.9 | Buy |
| 20-day EMA: | 18.44 | Buy |
| 50-day EMA: | 19.52 | Buy |
| 200-day EMA: | 27.59 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 58.11 | Buy |
| Chaikin Money Flow: | -260707 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17 - 18.86) | Buy |
| Bollinger Bands (100): | (18.23 - 27.59) | Sell |
Apellis Pharmaceuticals Technical Analysis
| May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 19.58 while APLS 8-day simple moving average is 18.84, which is a Buy signal.
-
The stock price of APLS is 19.58 while Apellis Pharmaceuticals 20-day SMA is 17.92, which makes it a Buy.
-
Apellis Pharmaceuticals 50-day simple moving average is 18.66 while APLS share price is 19.58, making it a Buy technically.
-
APLS stock price is 19.58 and Apellis Pharmaceuticals 200-day simple moving average is 27.56, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
47
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a SellThe current Apellis Pharmaceuticals [APLS] share price is $19.58. The Score for APLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
2.5B
Price in USD:
19.58
Share Volume:
1.7M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
43.76
52-Week Low:
16.10
Sell
47
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?The Apellis Pharmaceuticals stock price is 19.58 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 19.58 while APLS 8-day exponential moving average is 18.90, which is a Buy signal.
-
The stock price of APLS is 19.58 while Apellis Pharmaceuticals 20-day EMA is 18.44, which makes it a Buy.
-
Apellis Pharmaceuticals 50-day exponential moving average is 19.52 while APLS share price is 19.58, making it a Buy technically.
-
APLS stock price is 19.58 and Apellis Pharmaceuticals 200-day simple moving average is 27.59, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is 0.14, suggesting Apellis Pharmaceuticals is a Buy
-
Apellis Pharmaceuticals Relative Strength Index (RSI) is 58.11, which suggest Apellis Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Apellis Pharmaceuticals is (17 - 18.86), which suggest Apellis Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Apellis Pharmaceuticals is (18.23 - 27.59), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.